Redeye reiterates its positive view on Speqta as the company reported sequential growth despite COVID-19 challenges, and we maintain a positive outlook. The company´s sales came in stronger than expected, and the company seems to handle the second wave of the pandemic well. Looking beyond the pandemic, we believe that Speqta is a winner as we expect to see a strong recovery, especially for Rahalaitos. Hence, we maintain our positive stance on Speqta and continue to see a significant upside in the stock.